Lung cancers are carcinomas that derive from epithelial cells with small-cell lung carcinoma (SCLC), and non-small-cell lung carcinoma (NSCLC) being the main types. The estimated deaths from lung cancer is 159,480 (87,260 in men and 72,220 among women), accounting for about 27% of all cancer death. Worldwide, there are 2.28 million new cases of lung cancer annually, with 1.59 million deaths, making lung cancer a leading cause of cancer-related mortality and account for an estimate of about 14% of all new cancer. Tobacco use, particularly of smoking, is the main contributor to lung cancer; however, a significant number of non-smoking individuals are reported with lung cancer. Males show higher mortality rate because of increased risk of lung cancer associated with cigarette smoking . Approximately reporting 63,000 new lung cancer cases each year in India. Impediment in early detection and diagnosis of advanced stage is the main reason for high mortality. Following such stringent rules and evaluation can be costly, so publishers charge from the users who access the information, but, it will obstruct research as young researchers can afford it. Alternatively, fees can be charged from the researcher who has made the research and it can be free to the user who is interested in research thus, increasing the popularity and reputation to scholar and enhancing knowledge to user. OMICS is one such organization which freely publishes online journals where quality information resides and students, academicians etc can improve their knowledge by freely accessing these journals. OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals. Molecular Biology is one of the best online open access journals which publish original research, review, Short communication, and Case study in the field of Molecular Biology and its current research. It has world quality editorial board members in order to develop its standards.
Last date updated on July, 2014